AMRX

AMNEAL PHARMACEUTICALS INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

AMNEAL PHARMACEUTICALS INC (AMRX) is held as common stock by 3 tracked hedge-fund managers, with a combined reported value of ~$21.13M; the largest are Ken Griffin, Renaissance Technologies, Izzy Englander. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 added, 2 trimmed, 2 closed. 4 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · LowThis quarter · Cooling

Common-stock holders31 also report options

Congress trades4

Price$20.20vs quarter-end+16.70%

Sectors0

This quarter's moves

New0

Added1

Trimmed / sold4

Top holder

Ken Griffin

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Investor	Period	Value	Shares	% of portfolio	Action

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinCALL—

Value $507.2K— of portfolio29,3002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinCALL	2026 Q2	$507.2K	29,300	—	—

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.